149 related articles for article (PubMed ID: 38288969)
1. Hypoxia-related Y RNA fragments as a novel potential biomarker for distinguishing metastatic oral melanoma from non-metastatic oral melanoma in dogs.
Hasan MN; Rahman MM; Husna AA; Kato D; Nakagawa T; Arif M; Miura N
Vet Q; 2024 Dec; 44(1):1-8. PubMed ID: 38288969
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA and transfer RNA-derived small fragments in exosomes are potential biomarkers for canine oral melanoma.
Husna AA; Rahman MM; Chen HW; Hasan MN; Nakagawa T; Miura N
Vet Comp Oncol; 2022 Sep; 20(3):653-663. PubMed ID: 35388611
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of miR-301a and its functional roles in canine oral melanoma.
Hasan MN; Rahman MM; Husna AA; Arif M; Iwanaga T; Tsukiyama-Kohara K; Jasineviciute I; Kato D; Nakagawa T; Miura N
Vet Comp Oncol; 2024 Mar; 22(1):78-88. PubMed ID: 38148644
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic miRNAs expression are different between primary and metastatic melanoma cells.
Hino Y; Rahman MM; Lai YC; Husna AA; Chen HW; Hasan MN; Nakagawa T; Miura N
Gene; 2021 May; 782():145552. PubMed ID: 33705812
[TBL] [Abstract][Full Text] [Related]
5. Identification of melanoma-specific exosomal miRNAs as the potential biomarker for canine oral melanoma.
Husna AA; Rahman MM; Lai YC; Chen HW; Hasan MN; Nakagawa T; Miura N
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1062-1073. PubMed ID: 34273912
[TBL] [Abstract][Full Text] [Related]
6. Micro RNA Transcriptome Profile in Canine Oral Melanoma.
Rahman MM; Lai YC; Husna AA; Chen HW; Tanaka Y; Kawaguchi H; Miyoshi N; Nakagawa T; Fukushima R; Miura N
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569419
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of four canine melanoma cell lines.
Inoue K; Ohashi E; Kadosawa T; Hong SH; Matsunaga S; Mochizuki M; Nishimura R; Sasaki N
J Vet Med Sci; 2004 Nov; 66(11):1437-40. PubMed ID: 15585963
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly expressed snoRNA, snRNA, piRNA and tRFs in canine melanoma.
Rahman MM; Lai YC; Husna AA; Chen HW; Tanaka Y; Kawaguchi H; Hatai H; Miyoshi N; Nakagawa T; Fukushima R; Miura N
Vet Comp Oncol; 2020 Sep; 18(3):353-361. PubMed ID: 31769925
[TBL] [Abstract][Full Text] [Related]
10. Tissue transcriptome profiling and pathway analyses revealed novel potential biomarkers in the tumor progression of canine oral melanoma.
Pisamai S; Edwards SW; Cheng CW; Chaivichit P; Sooksiri M; Yanakam S; Maneewong S; Suriyaphol G
Res Vet Sci; 2023 Dec; 165():105036. PubMed ID: 37856944
[TBL] [Abstract][Full Text] [Related]
11. PTEN, A Target of Microrna-374b, Contributes to the Radiosensitivity of Canine Oral Melanoma Cells.
Noguchi S; Ogusu R; Wada Y; Matsuyama S; Mori T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540513
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.
Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B
Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840
[TBL] [Abstract][Full Text] [Related]
13. Analysis of canine myeloid-derived suppressor cells (MDSCs) utilizing fluorescence-activated cell sorting, RNA protection mediums to yield quality RNA for single-cell RNA sequencing.
Jackson K; Milner RJ; Doty A; Hutchison S; Cortes-Hinojosa G; Riva A; Sahay B; Lejeune A; Bechtel S
Vet Immunol Immunopathol; 2021 Jan; 231():110144. PubMed ID: 33278779
[TBL] [Abstract][Full Text] [Related]
14. Development of a multiple-marker polymerase chain reaction assay for detection of metastatic melanoma in lymph node aspirates of dogs.
Catchpole B; Gould SM; Kellett-Gregory LM; Dobson JM
Am J Vet Res; 2003 May; 64(5):544-9. PubMed ID: 12755292
[TBL] [Abstract][Full Text] [Related]
15. Novel Y RNA-Derived Fragments Can Differentiate Canine Hepatocellular Carcinoma from Hepatocellular Adenoma.
Ushio N; Hasan MN; Arif M; Miura N
Animals (Basel); 2023 Sep; 13(19):. PubMed ID: 37835660
[TBL] [Abstract][Full Text] [Related]
16. [Case report: oral malignant melanoma in an 11-month-old Dobermann].
Ballinari U; Schiller I; Schroff-Ballinari A; Mazzi M
Schweiz Arch Tierheilkd; 1998; 140(3):110-3. PubMed ID: 9528347
[TBL] [Abstract][Full Text] [Related]
17. Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.
Kawabe M; Baba Y; Tamai R; Yamamoto R; Komori M; Mori T; Takenaka S
J Vet Med Sci; 2015 Aug; 77(8):1025-8. PubMed ID: 25843037
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma.
Noguchi S; Mori T; Hoshino Y; Yamada N; Nakagawa T; Sasaki N; Akao Y; Maruo K
J Vet Med Sci; 2012 Jan; 74(1):1-8. PubMed ID: 21836381
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines.
Seo KW; Coh YR; Rebhun RB; Ahn JO; Han SM; Lee HW; Youn HY
Res Vet Sci; 2014 Jun; 96(3):482-6. PubMed ID: 24656746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
